Scarica l'app Stockscreener
114.43
1.55%
1.75
Dopo l'orario di chiusura:
114.41
-0.02
-0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott vs. Intuitive Surgical: Is Consistent Growth Better Than Premium Growth? - Yahoo Finance UK
Abbott Laboratories (ABT) Could Be 5% Undervalued Following MiniMed Pump Launch - simplywall.st
UnitedHealth Stock And 2 Dividend Names For Investors Seeking Stability - simplywall.st
Abbott settles appeal over $495 million infant formula verdict - Reuters
Abbott settles appeal of $495 million infant formula verdict - Investing.com
Richard W. Allen of Georgia’s 12th district makes significant trades in Abbott Laboratories and Advanced Micro Devices - Investing.com India
Abbott Laboratories posts 4.8% sales growth in Q2 2026, driven by nutrition, diagnostics, and devices. - Pluang
Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst - The Globe and Mail
Abbott Laboratories: Diagnostics And Medical Devices Fuel Next Growth Phase (Downgrade) - Seeking Alpha
The Smartest Dividend ETF to Buy With $500 Right Now - The Globe and Mail
5 questions on Abbott’s glucose-ketone sensors - MedTech Dive
Abbott Laboratories raises earnings outlook aft... - Pluang
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? - The Motley Fool
Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term - Seeking Alpha
IFP Advisors Inc Purchases 176,649 Shares of Abbott Laboratories $ABT - MarketBeat
Thomasville National Bank Acquires Shares of 19,194 Abbott Laboratories $ABT - MarketBeat
Smith & Nephew drops 3.5% as finance chief quits - proactiveinvestors.co.uk
Allied Investment Advisors LLC Buys 17,762 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Abbott Laboratories stock holds above $110 as consensus target stays higher - ad-hoc-news.de
Sibionics Loses 2nd Bid At Nixing Abbott Patent - Law360
Abbott (NYSE:ABT) Valuation Focus Grows With Lingo AI Expansion - Kalkine Media
Abbott and NACHC Launch Multi-Year Initiative to Embed Nutrition Into Primary Care at Community Health Centers - Nutritional Outlook
Abbott (ABT) Stock May Be 27% Undervalued As Lingo AI Tie Up Grows - simplywall.st
Moody Lynn Lieberson & Walker LLC Has $22.52 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Prevail Innovative Wealth Advisors LLC Invests $2.83 Million in Abbott Laboratories $ABT - MarketBeat
Liberty Capital Management Inc. Invests $3.14 Million in Abbott Laboratories $ABT - MarketBeat
Merit Financial Group LLC Has $7.06 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stock Holdings Lowered by Diversified Trust Co. - MarketBeat
Harmony Asset Management LLC Takes Position in Abbott Laboratories $ABT - MarketBeat
GRIMES & Co WEALTH MANAGEMENT LLC Cuts Stock Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Unloaded Rep. Richard McCormick - MarketBeat
Abbott Business Networks, LLC shifts business model to consulting - The Laconia Daily Sun
Abbott and NACHC launch Food for Health to boos... - Pluang
Abbott (ABT) Stock Looks Reasonable On Earnings With Stronger Cash Flow - Yahoo Finance
Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare - Chain Drug Review
What Does Abbott Laboratories (ABT) Gain From This New App Controlled Pump Rollout? - Yahoo Finance
Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Stock - Benzinga
MiniMed Inc And Abbott Laboratories Begin Shipping MiniMed Flex System With Instinct Sensor In United States - marketscreener.com
Abbott Laboratories (ABT) Investor Outlook: Navigating a 7.33% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
HM Payson & Co. Sells 15,789 Shares of Abbott Laboratories $ABT - MarketBeat
Cidel Asset Management Inc. Sells 184,792 Shares of Abbott Laboratories $ABT - MarketBeat
Fairvoy Private Wealth LLC Has $361,000 Stock Position in Abbott Laboratories $ABT - MarketBeat
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 20,339 Shares of Abbott Laboratories $ABT - MarketBeat
Fifth Third Wealth Advisors LLC Decreases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Asio Capital LLC Buys Shares of 37,689 Abbott Laboratories $ABT - MarketBeat
Park National Corp OH Lowers Stake in Abbott Laboratories $ABT - MarketBeat
Matrix Asset Advisors Inc. NY Invests $4.29 Million in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Revenue Breakdown – AQUISUK:ABLD - tradingview.com
Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health? - Yahoo Finance
Court Dismisses Amended Securities Complaint Against Abbott Laboratories - TipRanks
Abbott Opposes Consolidating 23 Spinal Cord Stimulator Injury Lawsuits - Medical Device and Diagnostic industry
Strong Buy Case for Abbott Laboratories (ABT) - Yahoo Finance
Abbott Seeks UK Ban On Chinese Rival's Glucose Monitors - Law360
Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating, Announces Target Price $125 - moomoo.com
Thompson Investment Management Inc. Has $1.28 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Toth Financial Advisory Corp Decreases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Cox Capital Mgt LLC - MarketBeat
Clark & Stuart Inc Has $3.12 Million Position in Abbott Laboratories $ABT - MarketBeat
Top Abbott Executive Makes Bold Move With Fresh Insider Stock Sale - TipRanks
Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle - Investing.com
Abbott And Google Partner To Bring Lingo Glucose Data Into Google Health App - insights.citeline.com
Google and Abbott Partner to Boost Metabolic Health Insights - Healthcare Digital
What's Backing Abbott's Established Pharmaceuticals Division Growth - The Globe and Mail
Wolfe Cuts Stryker, Backs Abbott in Med-Tech Shift - TradingPedia
Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research - MarketBeat
Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating - marketscreener.com
2.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):